Cargando…
Elevated expression of HDAC6 in clinical peritoneal dialysis patients and its pathogenic role on peritoneal angiogenesis
Peritoneal dialysis (PD) is an important renal replacement therapy for end-stage renal disease (ESRD) patients. However, its complications, such as peritoneal fibrosis (PF) and angiogenesis can cause ultrafiltration failure and PD termination. Histone deacetylase 6 (HDAC6) has been demonstrated to b...
Autores principales: | Shi, Yingfeng, Ni, Jun, Tao, Min, Ma, Xiaoyan, Wang, Yi, Zang, Xiujuan, Hu, Yan, Qiu, Andong, Zhuang, Shougang, Liu, Na |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7472510/ https://www.ncbi.nlm.nih.gov/pubmed/32862739 http://dx.doi.org/10.1080/0886022X.2020.1811119 |
Ejemplares similares
-
The prognosis and risk factors of baseline high peritoneal transporters on patients with peritoneal dialysis
por: Huang, Guansen, et al.
Publicado: (2021) -
A retrospective study of baseline peritoneal transport character and left ventricular hypertrophy in incident peritoneal dialysis patients: interrelationship and prognostic impacts
por: Wang, Yi, et al.
Publicado: (2023) -
Analysis of risk factors and outcome in peritoneal dialysis patients with early-onset peritonitis: a multicentre, retrospective cohort study
por: Ma, Xiaoyan, et al.
Publicado: (2020) -
Clinical outcomes, quality of life, and costs evaluation of peritoneal dialysis management models in Shanghai Songjiang District: a multi-center and prospective cohort study
por: Ma, Xiaoyan, et al.
Publicado: (2021) -
Histone deacetylase 6 inhibition counteracts the epithelial–mesenchymal transition of peritoneal mesothelial cells and prevents peritoneal fibrosis
por: Xu, Liuqing, et al.
Publicado: (2017)